Skip to main content
. Author manuscript; available in PMC: 2011 May 27.
Published in final edited form as: J Med Chem. 2010 May 27;53(10):3899–3906. doi: 10.1021/jm901446n

Figure 3. Inhibition of vaccinia virus growth by N1L antagonists.

Figure 3

A. VacV-GFP growth inhibition EC50 values obtained in CV1 and HT1080 cell lines. B. Ligand cytotoxicity in the absence of VacV-GFP. The indicated ligands were added to the cells at 150 μM. The ligand numbering corresponds to that of the Table 1.